Qi-Ju-Di-Huang-Pill delays the progression of diabetic retinopathy.
Zhao C, Ma G, Tao S, Wang M, Chen Z, Fang Y, Shi W.
J Ethnopharmacol. 2024 Apr 6;323:117751. doi: 10.1016/j.jep.2024.117751. Epub 2024 Jan 10.
Multimodal diagnostic imaging in primary vitreoretinal lymphoma.
Xu LT, Huang Y, Liao A, Anthony CL, Voloschin A, Yeh S.
Int J Retina Vitreous. 2022 Aug 26;8(1):58. doi: 10.1186/s40942-022-00405-0.
Clinical features and treatment outcomes of intraocular lymphoma: a single-center experience in China.
Di Y, Xu HY, Ye JJ, Li MD.
Int J Ophthalmol. 2021 Apr 18;14(4):574-581. doi: 10.18240/ijo.2021.04.15. eCollection 2021.
Primary Intraocular Lymphoma: Rad-Path and Ophthalmologic Correlation.
Szekeres D, Parker J, Risch E, Vibhute P, Bathla G, Agarwal S, Agarwal A, Soni N.
AJNR Am J Neuroradiol. 2024 Sep 30:ajnr.A8517. doi: 10.3174/ajnr.A8517. Online ahead of print.
Helicobacter pylori and association between its positivity and anatomotopographic settlement in the stomach with the host age range.
Ozturk T, Sengul D, Sengul I.
Ann Afr Med. 2021 Jan-Mar;20(1):1-8. doi: 10.4103/aam.aam_69_19.
TRIANGULAR SIGN OF AMALRIC IN INTRAVASCULAR LYMPHOMA.
Bavinger JC, Hamedani AG, Lee V, Brucker AJ, Aleman TS.
Retin Cases Brief Rep. 2022 Jan 1;16(1):20-24. doi: 10.1097/ICB.0000000000001042.
[Isolated primary vitreoretinal lymphoma (case report)].
Stoyukhina AS, Korobov EN, Smolin SA.
Vestn Oftalmol. 2024;140(2. Vyp. 2):94-101. doi: 10.17116/oftalma202414002294.
Retinal and Choroidal Changes of Vitreoretinal Lymphoma from Active to Remission Phase after Intravitreal Rituximab.
Cicinelli MV, Marchese A, Miserocchi E, Giuffré C, Berchicci L, Querques G, Bandello F, Modorati GM.
Ocul Immunol Inflamm. 2020 May 18;28(4):637-646. doi: 10.1080/09273948.2019.1616769. Epub 2019 Aug 8.
Retinal changes of primary vitreoretinal lymphoma after intravitreal methotrexate.
Jiang T, Gu J, Liu S, Chang Q.
BMC Ophthalmol. 2022 Sep 20;22(1):375. doi: 10.1186/s12886-022-02604-7.
Multimodal imaging characteristics in eyes with vitreoretinal lymphoma treated with intravitreal rituximab.
Rishi P, Maitra P, Das K, Rishi E, Manchegowda PT.
Int Ophthalmol. 2021 Aug;41(8):2711-2722. doi: 10.1007/s10792-021-01828-8. Epub 2021 Apr 8.
